Acumen Research and Consulting, a global provider of market research studies, in a recently added forthcoming report titled “FeNO Testing Market – Global Industry Analysis, Market Size, Opportunities ...

Aerocrine AB announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. According to a release, Aerocrine has received ...

NEW YORK, United States, June 19, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “China FeNO Testing Market 2022-2030” in its research database. According to ...

This case study has been carried out by Carol Stonham MBE, a Medical Advisory Board member. Carol has worked as a registered nurse since 1986, shifting from acute hospital care to primary care by 1990 ...

A meta-analysis shows that fractional exhaled nitrous oxide (FeNO) is a good evidence-based adjunct test for asthma A meta-analysis published in Mayo Clinic Proceedings shows that fractional exhaled ...

Asthma is a condition in which inflammation of the airways causes breathing difficulties. Today all of us are susceptible to asthma due to increasing pollution and allergies. But there's a method ...

As of Tuesday 24 th March, the number of global Coronavirus cases rose to 398,834 with 6,650 confirmed cases in the UK alone. The Covid-19 strain of Coronavirus has officially been declared a pandemic ...

One of the most difficult aspects of caring for patients with asthma is grading the severity of airways obstruction. Clinical assessment by interview is subjective and can be misleading, whereas ...

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) announces that Texas Medicaid will begin coverage of FeNO testing on April 1, 2013. The Texas Health and Human Services ...

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) announces that Health Care Service Corporation will begin covering FeNO testing for asthma ...